📰 Preserved Ejection News
Page 2 - Preserved Ejection News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Preserved Ejection. Real-time updates on events, politics, business and more.
October 10, 2022
Positive Data Presented at HFSA Annual Meeting Demonstrate Effects of Oral Levosimendan in Patients with Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction (PH-HFpEF) - read this article along with other careers information, tips and advice on BioSpace
October 5, 2022
New data presented at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2022, held Sept. 30-Oct. 3 in Washington, DC, shed light on the impact of an FDA-cleared blood volume analysis test to benefit patients with heart failure. During the HFSA Meeting, Daxor Corporation announced new data from multiple studies validating the benefits of the company’s BVA-100 blood test for patients with heart failure.
August 30, 2022
Data extend the clinically meaningful benefits of FARXIGA in patients with heart failure regardless of ejection fraction
August 27, 2022
Results presented at European Society of Cardiology Congress 2022, and published in New England Journal of Medicine Data extend the clinically meaning
October 20, 2021
The pipeline of Heart failure is robust, with 100+ giant players in the pipeline, and new therapeutic strategies are being explored. ...
May 17, 2021
Top experts from Brigham and Womens Hospital presented outcomes from some of the most-anticipated clinical trials in cardiology at the virtual American College of Cardiologys 70th Annual Scientific Session. In four Late-Breaking Clinical Trial presentations, Brigham cardiologists shared their latest findings on strategies to prevent future cardiovascular events in at-risk patient populations, results of a randomized clinical trial of a statin drug among patients critically ill with COVID-19, and...
February 10, 2021
UB’s Clinical and Translational Science Institute (CTSI) has awarded 13 new grants to support innovative translational research projects in Western New York. The CTSI Translational Pilot Studies Program provides seed money to investigators to assist them in developing promising new technologies and therapeutics from the conceptual stage to clinical studies. “The pilot studies grant awardees for 2021-22 include projects that address significant translational research questions,” says CTSI ...